Daratumumab bulk supplier for pharma manufacturers

Daratumumab 100 mg/5 mL, 400 mg/20 mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg/5 mL, 400 mg/20 mL

Reference Brands: Darzalex (USA/EU)

Daratumumab is a human monoclonal antibody and a targeted immunotherapy used primarily in the treatment of multiple myeloma and light chain (AL) amyloidosis. It works by binding to CD38, a protein highly expressed on malignant plasma cells, and induces cancer cell death through multiple mechanisms including complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and apoptosis.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Daratumumab — third party manufacturing & bulk supply

Daratumumab 100 mg/5 mL, 400 mg/20 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Daratumumab is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Daratumumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Daratumumab →

Back to Listing

Frequently Asked Questions

Daratumumab is listed as Injection in 100 mg/5 mL, 400 mg/20 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Daratumumab is referenced against Darzalex (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.